Insider Transactions Reported by 24 Insiders of BeOne Medicines Ltd.

Symbol
ONC on Nasdaq, BEIGF on OTC
Location
Basel

Insiders trading volume in the past year

BeOne Medicines Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
HHLR ADVISORS, LTD. 10%+ Owner $25B 02 Dec 2024
AMGEN INC 10%+ Owner $3.42B 10 Sep 2021
BAKER BROS. ADVISORS LP Director $2.14B -$191M -8.19% 21 May 2025
JOHN OYLER Chief Executive Officer, Director $1.79B -$110M -5.8% 15 Dec 2025
Xiaodong Wang Director, Chair, Scientific Advisory Brd $1.56B -$60.8M -3.75% 07 Nov 2025
Donald W. Glazer Director $565M 05 Jun 2024
Lai Wang Global Head of R&D $500M -$5.6M -1.11% 09 Sep 2025
Howard Liang CFO & Chief Strategy Officer $323M 28 Jun 2021
Xiaobin Wu President and COO $302M -$76.8M -20.3% 17 Nov 2025
Julia Aijun Wang Chief Financial Officer $88.6M 01 Jul 2024
Chan Henry Lee SVP, General Counsel $82.2M -$12.1M -12.8% 10 Dec 2025
Aaron Rosenberg Chief Financial Officer $54.6M -$346K -0.63% 01 Aug 2025
Jane Huang CMO, Hematology $33.2M 14 Dec 2021
Titus B. Ball Principal Accounting Officer $22.3M -$74.5K -0.33% 02 Sep 2025
(Corsee) Sanders Corazon Director $17.7M -$1.79M -9.18% 26 Nov 2025
ANTHONY C. HOOPER Director $15.9M 21 May 2025
Thomas Malley Director $15.1M 15 Jun 2023
Margaret Dugan Director $13.9M 21 May 2025
Alessandro Riva Director $13.9M 21 May 2025
OLIVIER BRANDICOURT Director $6.69M 21 May 2025
Qingqing Yi Director $6.37M 10 Jun 2025
Shalini Sharp Director $4.69M 21 May 2025
Jingshyh S. su Director $1.62M 16 Jun 2021
Timothy Yung-Cheng Chen Director $1.62M 16 Jun 2021

Recent Insider Transactions by Companies or Individuals for BeOne Medicines Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.